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Abstract. 
 
The adenoviral early region 4 open reading 
frame 4 (E4orf4) death factor induces p53-independent 
apoptosis in many cell types and appears to kill selec-
tively transformed cells. Here we show that expression 
of E4orf4 in transformed epithelial cells results in early 
caspase-independent membrane blebbing, associated 
with changes in the organization of focal adhesions and 
actin cytoskeleton. Evidence that E4orf4 can associate 
with and modulate Src family kinase activity, inhibiting 
Src-dependent phosphorylation of focal adhesion ki-
nase (FAK) and paxillin while increasing phosphoryla-
tion of cortactin and some other cellular proteins, is 
presented. Furthermore, E4orf4 dramatically inhibited 
the ability of FAK and c-src to cooperate in induction 
of tyrosine phosphorylation of cellular substrates, sug-
gesting that E4orf4 can interfere with the formation of 
a signaling complex at focal adhesion sites. Consistent 
with a functional role for E4orf4–Src interaction, over-
expression of activated c-src dramatically potentiated 
E4orf4-induced membrane blebbing and apoptosis, 
whereas kinase dead c-src constructs inhibited E4orf4 
effects on cell morphology and death. Moreover treat-
ment of E4orf4-expressing cells with PP2, a selective 
Src kinase inhibitor, led to inhibition of E4orf4-depen-
dent membrane blebbing and later to a marked de-
crease in E4orf4-induced nuclear condensation. Taken 
together, these observations indicate that expression of 
adenovirus 2 E4orf4 can initiate caspase-independent 
extranuclear manifestations of apoptosis through a 
modulation of Src family kinases and that these are in-
volved in signaling E4orf4-dependent apoptosis. This 
study also suggests that Src family kinases are likely to 
play a role in the cytoplasmic execution of apoptotic 
programs.
Key words: actin • blebbing • Src family kinase •
focal adhesion kinase • cortactin
 
Introduction
 
During the last several years, a tremendous amount of
work has led to new insights into the mechanisms underly-
ing the central executioner core of the apoptotic machin-
ery, which plays a crucial role in the maintenance of cellu-
lar integrity (Thompson, 1995). Two major execution
programs downstream of the death signal have emerged,
one of which is the caspase pathway by which limited pro-
teolysis of specific substrates lead to activation of enzyme
activities, or inactivation of essential cellular components
(Martin and Green, 1995; Nicholson and Thornberry,
1997). The second major execution program, the mito-
chondrial pathway, leads to release of proapoptotic mole-
cules, some of which are involved in the activation of the
so-called apoptosome (for review see Green and Reed,
1998 and Thornberry and Lazebnick, 1998; Kroemer et al.,
1995). Despite the well-established importance of caspases
in apoptotic processes, the existence of a caspase-indepen-
dent pathway for execution of cell death is evidenced by
molecules that can induce apoptosis, without the need for
caspase activation; these include the proapoptotic Bcl-2
family members BAX and BAK (Xiang et al., 1996; Mc-
Carthy et al., 1997), AIF (which is released from mito-
chondria during apoptosis; Susin, et al., 1999), and expres-
sion of the adenovirus (Ad)
 
1
 
 early region 4 open reading
frame 4 (E4orf4) death factor (Lavoie et al., 1998).
 
Apoptosis is also associated with profound modifications
in the cytoplasmic architecture of cells, which are mani-
fested by changes in adhesive mechanisms and localization
of cytoskeletal proteins, induction of a rounded morphol-
ogy, membrane blebbing, and shrinkage of the cells (for
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review see Mills et al., 1999). Recently, a model was pro-
posed to recapitulate the mechanisms underlying the cyto-
plasmic execution phase of apoptosis, or extranuclear ap-
optosis, into three sequential phases: the release stage,
blebbing, and the final condensation stage (Mills et al.,
1999). The first stage is characterized by a reorganization
of focal adhesions and actin changes to allow a rounder
morphology (Bannerman et al., 1998; Huot et al., 1998;
Levkau et al., 1998). Based on this model, the physiologi-
cal apoptotic process induced by loss of extracellular ma-
trix (ECM) attachments (anoikis) would represent a direct
entry of cells into the release stage of the cytoplasmic exe-
cution of death. Cell–ECM interactions via integrin recep-
tors promote the assembly of cytoskeletal and signaling
molecules at sites called focal adhesion. These signaling
complexes include Src family kinase members, focal adhe-
sion kinase (FAK), adaptor molecules, phosphatidylinosi-
tol-3
 
9
 
-kinase, and phospholipase C (Miyamoto et al., 1995a,b;
Plopper et al., 1995), and are involved in the propagation
of survival signals via activation of downstream signaling
pathways (for review see Giancotti, 1997). The importance
of FAK in regulating adhesion-dependent cell survival
was demonstrated by the development of a constitutively
activated form of FAK that resulted in a substantial pro-
tection of MDCK cells from anoikis (Frisch et al., 1996).
Furthermore, inactivation of FAK by microinjection of
specific peptides was shown to induce apoptosis (Hunger-
ford et al., 1996). However, it is not understood how inte-
grins, cell shape, and apoptotic signaling are integrated,
and study of cytoplasmic events has lagged.
Recently, we and others have shown that expression of
the Ad E4orf4 protein in several mammalian cell lines in-
duces a p53-independent apoptotic pathway (Shtrichman and
Kleinberger, 1998;Lavoie et al., 1998; Marcellus et al.,
1998). E4orf4 appears to kill transformed cells more selec-
tively, as expression of oncogene in primary cell cultures
was reported to sensitize these cells to E4orf4-induced ap-
optosis (Shtrichman et al., 1999). E4orf4-mediated apop-
tosis does not require activation of the zVAD-fmk–inhib-
itable caspases, and is associated with mitochondrial
dysfunctions in CHO cells (Lavoie et al., 1998). Other cel-
lular processes such as downregulation of virally induced
signal transduction (Bondesson et al., 1996), regulation of
gene expression (Muller et al., 1992), and differential splic-
ing of adenovirus late mRNA (Kanopka et al., 1998) have
been shown to be affected by Ad E4orf4. Additionally,
E4orf4 was found to associate with the B55 subunit of pro-
tein phosphatase 2A (PP2A; Kleinberger and Shenk, 1993),
and very recently a close correlation between E4orf4 bind-
ing to PP2A and induction of apoptosis was reported in
mutagenesis experiments (Shtrichman et al., 1999; Marcel-
lus et al., 2000); however, no molecular mechanism was
proposed to explain how E4orf4/PP2A interaction could
transduce E4orf4 apoptotic signal. The mechanisms un-
derlying initiation and execution of E4orf4 death pathway
are still not understood, and the observations that this
pathway appears to be p53-caspase–independent and spe-
cific to transformed cells is of great interest.
In this study, we report that E4orf4 initiates early mor-
phological changes leading to membrane blebbing and
provide evidence that these manifestations are involved in
the propagation of E4orf4 death signal. We found that
 
E4orf4 can associate with Src family kinases and dysregu-
late Src-dependent signaling. Moreover, the data obtained
strongly suggest that Src family kinase activity plays a role
in signaling caspase-independent E4orf4-induced mem-
brane blebbing and nuclear condensation.
 
Materials and Methods
 
Expression Vectors and Mutagenesis
 
 NH
 
2
 
-terminal epitope-tagged forms of Ad2 E4orf4 were generated by
standard PCR method and subcloned into mammalian expression vectors.
The Flag–E4orf4 construct was generated using a hemagglutinin (HA)-orf4/
PUHD10-3 as the template (Lavoie, et al., 1998), and the sense and anti-
sense oligos 5
 
9
 
-GGGGTACCG ATG GTT CTT CCA GCT CTT CC-3
 
9
 
and 5
 
9
 
-CTA CTG TAC GGA GTG CGCC-3
 
9
 
, respectively. The resulting
DNA fragment was subcloned into the KpnI–EcoRV sites of pcDNA3
FLAG type A (Invitrogen). All subsequent PCRs were performed using
the Flag–E4orf4 construct as the DNA template. The myc–E4orf4 con-
struct was obtained by using the sense and antisense oligos 5
 
9
 
-GGGG-
TACCG ATG GTT CTT CCA GCT CTT CC-3
 
9
 
 and 5
 
9
 
-ATTTAGGT-
GACACTATAG-3
 
9
 
 (SP6 primer), respectively, and the resulting DNA
fragment was subcloned in frame into the EcoRI restriction site of the
pCineo-myc vector (Theriault et al., 1999). The Flag–green fluorescent
protein (GFP) expression vector has been described by Lee et al., 1999.
The Flag–E4orf4–GFP construct was obtained by PCR using the sense
and antisense oligos 5
 
9
 
-AGAGGGCC C ATG GTT CTT CCA GCT CTT
CCA-3
 
9
 
 and 5
 
9
 
-GCA GAA TTC CTC GAG CTG TAC GGA GTG
CGC-3
 
9
 
, respectively. The resulting DNA fragment was digested with
ApaI and XhoI and inserted into the ApaI–XhoI sites of the Flag-GFP
vector. Expression vector containing the mouse c-src cDNA was obtained
from Dr. André Veillette (McGill University, Montréal, Québec, Can-
ada). Activated c-src was generated by replacing the COOH-terminal reg-
ulatory Tyr 527 by Phe residue as previously described (Courtneige, 1985;
Reynolds et al., 1987), using the QuickChange Site-Directed Mutagenesis
Kit (Stratagene). Two oligos, 5
 
9
 
-ACT GAG CCA CAG TTC CAG CCC
GGG GAG-3
 
9
 
 and 5
 
9
 
-CTC CCC GGG CTG GAA CTG TGG CTC
AGT-3
 
9
 
, were used to generate the mutation on mouse c-src. Kinase-defi-
cient c-src was obtained by inactivating the ATP binding site upon replac-
ing the Lys at position 295 by a Met residue as previously reported (Sny-
der et al., 1985; Roche et al., 1995), using the QuickChange Site-Directed
Mutagenesis Kit (Stratagene). The following sense and antisense oligos
were used to generate the mutation on mouse c-src: 5
 
9
 
-AGG GTT GCC
ATC ATG ACT CTG AAG CCA GGC ACC-3
 
9
 
 and 5
 
9
 
-GCC TGG CTT
CAG AGT CAT GAT GGC AAC CCT CGT-3
 
9
 
. In vitro kinase activities
of the mutant Srcs were analyzed after isolation of the Src proteins ex-
pressed into 293T cells, using Raytide peptide as substrate, according to
the manufacturer’s protocol (Oncogene Research Products). The v-src
construct was obtained by subcloning the avian v-src sequence into the
BamHI site of pCDNA3 vector (Invitrogen) and was a gift from Dr. Jerry
Pelletier (McGill University). Chicken c-srcY527F and c-srcK295R in
pLNCX vector were provided by Dr. J.S. Brugge (Harvard Medical
School, Boston, MA) and have been described previously (Thomas et al.,
1991). The myc-FAK expression vector was provided by Dr. J. Thomas
Parsons (University of Virginia School of Medicine, Charlottesville, Vir-
ginia) and has been described elsewhere (Xiong and Parsons, 1997). Au-
thenticity of all DNA fragments generated by PCR was confirmed by
DNA sequence analysis.
 
Glutathione S-Transferase Fusion Proteins and Rabbit 
2418 E4orf4 Antibody
 
The glutathione 
 
S
 
-transferase (GST)–E4orf4 fusion was generated by
PCR using the Flag–E4orf4 as template and the sense and antisense oligos
5
 
9
 
-GGGGTACC ATG GTT CTT CCA GCT CTT CC-3
 
9
 
 and 5
 
9
 
-ATT-
TAGGTGACACTATAG-3
 
9
 
 (SP6 primer), respectively. The DNA frag-
ment was processed for subcloning into the BamHI–XhoI sites of
pGEX4T-3 vector (Amersham Pharmacia Biotech). The GST-c-src was
produced by PCR using mouse c-src as template and the sense and anti-
sense oligos 5
 
9
 
-CAGGATCCAGGAATTCG ATG GGC AGC AAC
AAG AGC-3
 
9
 
 and 5
 
9
 
-CGCTCGAG CTA TAG GTT CTC CCC GGG-3
 
9
 
,
respectively. The resulting DNA fragment was subcloned into the EcoRI–
XhoI sites of pGEX4T-3 vector. The recombinant plasmids were intro-
duced into 
 
Escherichia coli
 
 BL21 DE3, and the fusion proteins were pro- 
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duced by growing 50-ml bacterial cultures to an OD between 0.9 and 1.1,
and then treating the cultures with 0.5 mM IPTG for 1.5–3 h. Cells were
recovered and resuspended in 1.5 ml of SB buffer (16 mM sodium phos-
phate, pH 7.4, 150 mM NaCl, 15% glycerol, 0.02% Triton X-100, 1 mM
DTT, 15 
 
m
 
g/ml leupeptin, 5 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml pepstatin A) and
sonicated using a Vibra Cell probe sonicator operating at setting 7.5 for
20 s at 4
 
8
 
C. Triton X-100 was added to the lysates to a final concentration
of 1%, and the bacterial lysates were incubated on ice for 15 min, then
centrifuged at 12,000 rpm in a Beckman SS34 rotor for 15 min. The super-
natants were recovered, mixed with 55 
 
m
 
l of a 1:1 suspension of glu-
tathione/Sepharose 4B beads, and the mixture was rotated at 4
 
8
 
C for 1 h.
The beads were then washed extensively in SB buffer and used for in vitro
binding assays, or the GST fusions were eluted from the beads with 100 mM
Tris-HCl, pH 8.0, 120 mM NaCl, 20 mM reduced glutathione. Purified
GST–E4orf4 fusion protein was injected into rabbits, then the immune se-
rums were absorbed on immobilized GST and the purified IgG fraction
was used in Western blot and immunofluorescence analyses. The specific-
ity of the resulting 2418 anti-E4orf4 was tested by Western blot analysis of
total cellular proteins from lysates of control cells versus lysates from cell
transfected with E4orf4 and myc–E4orf4, and by immunofluorescence
analysis of control cells versus cells transfected with E4orf4, showing spe-
cific staining only for cells transfected with E4orf4. The antibody also re-
acted specifically with immune complexes obtained upon immunoprecipi-
tation of transfected Flag–E4orf4 into 293T cells using anti-Flag.
 
Cell Culture, Transfections, and Apoptosis Assays
 
293T were derived from human embryonic kidney cells and express Ad5
E1A and E1B proteins and large T antigen (Graham et al., 1977). 293T
were maintained in DMEM and the human non–small-cell lung carcinoma
H1299 cells (Mitsudomi et al., 1992) were maintained in 
 
a
 
MEM. All cul-
ture media were supplemented with 10% FBS and streptomycin sulfate/
penicillin (100 U/ml). Cells were grown in a humidified 5% CO
 
2
 
 atmo-
sphere at 37
 
8
 
C. Transfections of 293T and H1299 were performed by the
calcium phosphate method when cells reached 50–60% confluency. Cells
were either seeded on regular culture dishes (H1299) or polylysine (293T;
10 
 
m
 
g/ml), or fibronectin-coated culture dishes when indicated (FALCON
Biocoat; Becton Dickinson). 293T cells were transfected with 15 
 
m
 
g total
DNA in 10-cm culture dishes, or with the corresponding ratio DNA/cells
in other culture dishes, and the calcium-phosphate-DNA precipitates
were left on cells for 7 h in the presence of chloroquine (25 
 
m
 
M). H1299
cells were transfected with 40 
 
m
 
g total DNA in 10-cm culture dishes or
with 15 
 
m
 
g total DNA in 6-well plates. Viability was assessed at 16–20 h by
Trypan blue exclusion assays, as previously described (Lavoie et al., 1998).
Morphological/spreading analysis of 293T cells transfected with Flag–
GFP, Flag–E4orf4–GFP, or Flag–GFP together with E4orf4 and/or Src
constructs were realized 20–24 h after transfection, using a Nikon Dia-
phot-TMD equipped with a Hoffman modulation system and a ther-
moregulated chamber at 37
 
8
 
C. Cell adhesion assays were performed by
plating cells (30,000 in serum-free media containing 0.5% BSA) on fi-
bronectin-coated 96-well tissue culture plates 20–24 h after transfections.
Cells were incubated at 37
 
8
 
C for 1 h, and adherent cells were quantified as
described by Masson-Gadais et al. (1997). In brief, attached cells were
gently washed with PBS and fixed in 1% glutaraldehyde/PBS for 30 min.
Fixed cells were stained for 15 min and extracted in 1% SDS, after which
absorbance was measured at 550 nm. Specific attachment to fibronectin
was controlled by incubating cell suspensions in the presence of integrin
 
b
 
1–blocking antibody (2 mg/ml, mouse anti–human integrin 
 
b
 
1 clone
P4C10, GIBCO-BRL) before plating cells on coated dishes. Treatments
with various drugs were performed by adding DMSO (0.2%), cytochalasin
D (1 
 
m
 
M; Sigma-Aldrich), PP2 or PP3 (50 
 
m
 
M; Calbiochem-Novabio-
chem), or genistein (100 
 
m
 
M; Sigma-Aldrich) directly to the culture me-
dium. After quantitative measurement of the various phenotypes, repre-
sentative fields were captured by confocal microscopy using a Bio-Rad
MRC-1024 imaging system mounted on a Nikon Diaphot-TMD equipped
with an 
 
3
 
20 objective lens as previously described (Lavoie et al., 1995).
Cells were kept in culture for an additional 24 h and the nuclear morphol-
ogy of GFP-positive cells was analyzed. Nonadherent and adherent cells
were washed in PBS, half of each cell suspension was lysed in SDS sample
buffer, and equal amounts of total proteins were run on SDS-PAGE for
Western blot analysis of expression levels of the exogenous proteins. The
other half of the cell suspensions were resuspended in 100% methanol,
fixed at 
 
2
 
20
 
8
 
C for 5 min, and air-dried on glass coverslips. Staining of
DNA was performed using 4
 
9
 
-6-diamidino-2-phenylindole dihydrochlo-
ride (DAPI; Molecular Probes) as previously described (Lavoie et al.,
 
1998), and specimens were analyzed by fluorescence microscopy using a
Nikon Eclipse E600 equipped with a Micromax CCD camera. All quanti-
tative measures were obtained by counting at least 300 cells and are repre-
sentative of three independent experiments.
 
In Vitro Binding Assays
 
Control 293T cells or transfected cells with myc–E4orf4 from a 10-cm
plate were washed in PBS and homogenized in 1.0 ml lysis buffer (50 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 0.5% sodium
deoxycholate, 10% glycerol, 1 mM Na
 
3
 
VO
 
4
 
, 15 
 
m
 
g/ml leupeptin, 5 
 
m
 
g/ml
aprotinin, 1 
 
m
 
g/ml pepstatin A, 1 mM 
 
b
 
-glycerophosphate). After centrif-
ugation at 11,000 
 
g
 
, supernatants were precleared with 50 
 
m
 
l of a 1:1 slurry
of glutathione/Sepharose 4B for 1 h at 4
 
8
 
C. The Sepharose was then re-
moved and the supernatants were incubated in the presence of 4 
 
m
 
g of im-
mobilized GST fusions, freshly prepared as described above, for 4 h at 4
 
8
 
C
(slurry of glutathione/Sepharose 4B was added up to 10 
 
m
 
l volume of
packed beads/sample). The beads were recovered by centrifugation,
washed three times in buffer containing 50 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 0.1% NP-40, and 10% glycerol, and were then boiled in SDS sample
buffer. The amount of E4orf4 absorbed was analyzed by Western blot us-
ing mouse 9E10 anti–c-myc antibody (Sigma-Aldrich). Binding of Src-
kinases, PP2A, and NCK to GST–orf4 fusion was assessed using rabbit
SRC2 anti-src-kinases antibody (Santa Cruz Biotechnology, Inc.), mouse
anti-PP2A catalytic 
 
a
 
 (Transduction Laboratories), or rabbit anti-NCK
(PharMingen) antibodies, respectively, for Western blot analysis of the
absorbed material.
 
Immunoprecipitations, Cell Fractionation, and Blotting
 
For coimmunoprecipitations of E4orf4-Src kinases, 293T cells were har-
vested 24 h after transfection, washed in PBS, and resuspended in 1.5 ml
hypotonic buffer (5 mM Tris-HCl, pH 7.4, 5 mM KCl, 1.5 mM MgCl
 
2
 
, 5 mM
EDTA, 1 mM Na
 
3
 
VO
 
4
 
, 15 
 
m
 
g/ml leupeptin, 5 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml pep-
statin) per 10-cm culture plate. Cells were allowed to swell on ice for 15
min, and were disrupted by five cycles of freeze–thaw interspersed by five
strokes with a Wheaton glass homogenizer fitted with a B pestle. Homog-
enates were centrifuged at 900 
 
g
 
 for 15 min at 4
 
8
 
C, yielding the first pellets
(P1) containing mainly nuclei and unbroken cells. Supernatants were then
centrifuged at 25,000 
 
g
 
 for 30 min at 4
 
8
 
C in a Beckman Ti75 rotor. The sec-
ond pellets (P2) contained mainly the nuclear membranes, plasma mem-
brane sheets, mitochondria, and Golgi sheets. The resulting supernatant
was referred as S. The two pellets were resuspended in 1.5 ml modified-
RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1%
NP-40, 0.5% sodium deoxycholate, 0.05% SDS, 1 mM Na
 
3
 
VO
 
4
 
, 15 
 
m
 
g/ml
leupeptin, 5 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml pepstatin A, 1 mM PMSF), and S
fractions were supplied with 45 mM Tris-HCl, pH 7.4, 125 mM NaCl, 1%
NP-40, 0.5% sodium deoxycholate, 0.05% SDS. Lysates were precleared
with protein G or A Sepharose (50 
 
m
 
l of 1:1 slurry) for 1 h at 4
 
8
 
C, and then
Sepharose was removed and lysates were incubated with mouse 9E10
anti–c-myc antibody (Sigma-Aldrich), or rabbit SRC2 anti-Src antibody
(Santa Cruz Biotechnology, Inc.) for 4–8 h at 4
 
8
 
C. Protein G or A
Sepharose was then added to the lysates (30 
 
m
 
l of a 1:1 slurry), and incuba-
tion at 4
 
8
 
C was pursued for another 1 h, after which the beads were recov-
ered, washed three times, and boiled in SDS sample buffer. Samples were
resolved on 10 or 12.5% SDS-PAGE, transferred to nitrocellulose, and
processed for immunoblotting using either mouse 9E10 anti–c-myc,
mouse Ab-1 anti–v-src antibody (Calbiochem-Novabiochem), or rabbit
SRC2 anti-Src antibody (Santa Cruz Biotechnology, Inc.). In vitro kinase
assays to measure autophosphorylation of FAK or Src kinase activity
were performed 20–24 h after the transfection. Cells were washed in PBS
and lysed in 1 ml modified RIPA buffer per 10-cm culture plate. After
centrifugation at 11,000 
 
g
 
, supernatants (equal amounts of total proteins)
were processed for immunoprecipitation as described above, using rabbit
C-20 anti-FAK (Santa Cruz Biotechnology, Inc.) or Ab-1 anti-src (Calbio-
chem-Novabiochem). The immune complexes were washed and resus-
pended in 20 
 
m
 
l 2
 
3
 
 kinase buffer (100 mM Tris-HCl, pH 7.0, 0.2% 
 
b
 
-mer-
captoethanol, 20 mM MgCl
 
2
 
, 0.2 mM Na
 
3
 
VO
 
4
 
). Reactions were started by
addition of 10 
 
m
 
Ci 
 
g
 
-[
 
32
 
P]ATP, allowed to proceed for 15 min at 30
 
8
 
C, and
then stopped by addition of 20 
 
m
 
l of 3
 
3
 
 SDS sample buffer. Samples were
boiled, resolved on 10% SDS-PAGE, and visualized by autoradiography.
To assess the tyrosine phosphorylation level of FAK, paxillin, and cortac-
tin, cells were lysed in 250 
 
m
 
l boiling SDS buffer (10 mM Tris-HCl, pH 7.4,
1% SDS, 1 mM Na
 
3
 
VO
 
4
 
) per 10-cm culture plate, boiled for 5 min, and
passed through a 26-gauge needle five times. 750 
 
m
 
l water and 1 ml 2
 
3 
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modified-RIPA buffer were added to the denatured lysates, and the ly-
sates (equal amounts of proteins) were processed as above for immuno-
precipitation using rabbit C-20 anti-FAK (Santa Cruz Biotechnology,
Inc.), mouse 349 antipaxillin (Transduction Laboratories), mouse 4F11 anti-
cortactin antibody (Upstate Biotechnology), or mouse PY20 antiphospho-
tyrosine (Transduction Laboratories). Tyrosine phosphorylation was ana-
lyzed by immunoblotting using mouse RC20–HRP antiphosphotyrosine
antibody (Transduction Laboratories), and levels of phosphorylated
FAK, paxillin, and cortactin recovered in the anti-PY20 immune com-
plexes were detected by immunoblotting with C20 anti-FAK, mouse 349
antipaxillin, or mouse 4F11 anticortactin, respectively. Protein concentra-
tions were determined using the Bio-Rad assay. For cell fractionation
analysis, transfected 293T cells from 6-cm culture dishes were lysed in Tri-
ton buffer (50 mM Tris-Hcl, pH 7.4, 150 mM NaCl, 0.5% Triton X-100,
10% glycerol, 1.5 mM MgCl
 
2
 
, 1 mM EDTA, 1 mM EGTA, 0.5 mM
Na
 
3
 
VO
 
4
 
, 15 
 
m
 
g/ml leupeptin, 5 
 
m
 
g/ml aprotinin, 1 
 
m
 
g/ml pepstatin A, 1
mM PMSF, and 50 mM NaF), vortexed, and incubated for 30 min on ice.
The lysates were then centrifuged at 12,000 
 
g
 
 for 15 min at 4
 
8
 
C, the pellets
were resuspended in 1 vol of Triton buffer, and 1 vol of 2
 
3
 
 SDS sample
buffer was added to each fraction. Equal volumes of the supernatant
(S) and pellet (I) fractions were analyzed by SDS-PAGE to determine the
relative amount of myc–E4orf4, Src kinases, and mitogen-activated pro-
tein (MAP) kinase extracellular-regulated kinase (ERK) in each fraction
by immunoblotting with mouse 9E10 anti–c-myc (Sigma-Aldrich), mouse
Ab-1 anti-src (Calbiochem-Novabiochem), and rabbit anti-ERK, respec-
tively. The anti-ERK is a rabbit polyclonal antibody raised against a syn-
thetic peptide corresponding to the 14 COOH-terminal amino acids of rat
ERK2 (Huot et al., 1995). Proteins were detected immunologically after
electrotransfer onto nitrocellulose membranes as described previously
(Lavoie et al., 1995). Horseradish peroxidase–linked goat anti–rabbit, or
anti–mouse IgG (Jackson ImmunoResearch Laboratories), revealed by the
enhanced chemiluminescence detection system (Renaissance; NEN Life
Science Products) was used to detect the antigen–antibody complexes.
 
Immunofluorescence and Confocal
Fluorescence Microscopy
 
Immunofluorescence analyses were performed in H1299 cells or 293T
cells plated on fibronectin-coated culture slides (FALCON Biocoat; Bec-
ton Dickinson Co.) 10–24 h after transfection. Cells were washed in PBS
containing 1 mM MgCl
 
2
 
, fixed in 3.7% formaldehyde/PBS for 20 min, and
then permeabilized in 0.2% Triton X-100/PBS for 5 min. Immunodetec-
tion of E4orf4 proteins was performed using either mouse 9E10 anti–c-myc
antibody (Sigma-Aldrich), mouse HA.11 anti-HA antibody (BabCO), or
purified rabbit polyclonal 2418 anti-E4orf4, as indicated in the figure leg-
ends, using previously described methods (Lavoie et al., 1995). Mouse an-
ticortactin antibody (Transduction Laboratories) was used to analyze
cortactin distribution, rabbit SRC2 anti-src antibody was used to detect
c-src, and mouse PY20 antiphosphotyrosine antibody was used to visual-
ize tyrosine phosphorylation at focal adhesion, followed by BODIPY-
labeled goat anti–mouse, or Texas Red–conjugated anti–rabbit IgG (Mo-
lecular Probes). Staining of actin filaments was performed as previously
reported (Lavoie et al., 1993), using FITC-labeled phalloidin. The cells
were examined by confocal microscopy as previously reported, using a
Bio-Rad MRC-1024 imaging system mounted on a Nikon Diaphot-TDM
equipped with an 
 
3
 
60 objective lens with a 1.4 numerical aperture
(Lavoie et al., 1995).
 
Results
 
E4orf4 Expression Induces Membrane Blebbing and 
Inhibition of Fibronectin-induced Cell Spreading
 
The first manifestations of E4orf4 expression in many cell
types is cell rounding and membrane blebbing. This early
effect of E4orf4 was striking in transformed cells and Fig. 1
shows examples of the early extranuclear manifestations
of apoptosis in 293T and H1299 cells. 10–20 h after trans-
fection of E4orf4, a large fraction of the 293T cell popula-
tion retracted from the culture plate adopting a rounded
morphology, and started to undergo dramatic membrane
blebbing (Fig. 1 A). E4orf4-transfected cells showed a
large number of prominent membrane blebs that covered
the entire cytoplasmic area (Fig. 1 A, arrows in b and c),
and this effect persisted until the onset of cell death. This
phenotype was dependent on E4orf4 expression because
transfection of a E4orf4–GFP fusion in either H1299 or
293T cells induced prominent membrane blebbing very
early after transfection (onset at 10 h after transfection),
whereas expression of GFP alone had no effect on cell
morphology (Fig. 1 B). Early changes in morphology in-
duced by E4orf4 expression were independent of caspase
activation, as they were still observed in the presence of
the pan-caspase inhibitor zVAD-fmk (Fig. 1, A and B)
when used at a concentration that inhibited cell fragmen-
tation induced by puromycin in the same cell lines (Fig. 1
B, bottom). E4orf4-induced membrane blebbing was ob-
served very early and clearly preceded cell death in 293T
cells, as judged by Trypan blue exclusion assays (data not
shown). This suggested that the blebbing-inducing activity
of E4orf4 could lie upstream in the death pathway.
To further study the effects of E4orf4 expression on cell
shape, transfections were performed into 293T cells and 20 h
later the kinetics of cell spreading on fibronectin was ana-
lyzed in vector only (EV)–transfected cells as compared
with cells transfected with E4orf4. 1 h after transferring
cells to fibronectin-coated dishes in serum-free media,
most of the empty vector-transfected cells had reattached
to the culture dish and displayed a spread morphology
(Fig. 1 C). In contrast, a majority of the cells transfected
with E4orf4 remained round as spreading was inhibited by
more than threefold over a 1-h period as compared with
cells transfected with EV. This was not caused by cell
death since at that time no significant effect on cell sur-
vival was observed (
 
,
 
10% cell death in EV- and E4orf4-
transfected cells as measured by Trypan blue exclusion).
Inhibition of cell spreading could be caused by E4orf4 in-
terference with signals induced by cell adhesion, or by in-
hibition of cell adhesion itself. To discriminate between
these two possibilities, we measured the ability of E4orf4-
expressing cells to adhere to ECM proteins. Transfected
293T cells were processed as above and cell adhesion to fi-
bronectin was quantitated as described in Materials and
Methods after the 1-h incubation period. No significant
difference was observed between control cells as com-
pared with E4orf4-expressing cells that adhered as well to
fibronectin (Fig. 1 D). When adhesion was measured after
incubating cells with integrin 
 
b
 
1–blocking antibody, adhe-
sion to fibronectin was severely impaired in control and
E4orf4-expressing cells, indicating that cell attachment to
fibronectin was specific. As E4orf4-expressing cells were
able to adhere to ECM but unable to spread, this suggests
that E4orf4 may interfere with the propagation of adhe-
sion signals.
 
E4orf4 Associates with Src Family Kinases
 
To determine whether E4orf4 could directly associate with
cellular proteins involved in the formation of focal adhe-
sion signaling complexes, pull-down assays were per-
formed using a GST–E4orf4 fusion to absorb naive 293T
cell lysates, and the absorbed material was analyzed by
Western blot using different antibodies. When a pan-Src
antibody recognizing multiple members of the src gene 
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family was used, we detected a significant amount of Src
family kinases bound to the GST–E4orf4 fusion as com-
pared with GST alone (Fig. 2 A, left). The GST–E4orf4 fu-
sion also pulled down the catalytic subunit of PP2A, as
previously reported (Kleinberger and Shenk, 1993). In
contrast, E4orf4 binding to the adaptor protein NCK was
barely detectable. The ability of E4orf4 to associate with
Src was further analyzed using a GST fusion of mouse c-src
to absorb lysates from 293T cells transfected with a myc-
tagged E4orf4. Addition of epitope-tag at the NH
 
2
 
 termi-
nus of E4orf4 has been shown previously to have no effect
on its apoptotic activity (Lavoie et al., 1998), nor did it in-
terfere with the localization of the protein (see Figs. 3 A
and 7). The results show that the c-src fusion pulled down
the expressed myc–E4orf4, further indicating that E4orf4
can associate with c-src in vitro (Fig. 2 A, right).
We then asked whether E4orf4–Src association could be
detected in vivo. Myc–E4orf4 was cotransfected into 293T
cells with a plasmid encoding v-src, and coimmunoprecipi-
tations were performed on cellular fractions. Using this
fractionation protocol, E4orf4 expression was enriched in
the P2 fraction containing mainly cellular membranes. More
Figure 1. Expression of E4orf4 is associated with early membrane blebbing and inhibition of fibronectin-induced cell spreading. (A)
293T cells were transfected with either vector alone (a) or myc–E4orf4 (b and c), and 16–20 h after transfection cells were observed by
phase contrast, using a Nikon Diaphot-TMD equipped with a Hoffman modulation system. The effect of zVAD-fmk was measured by
adding the pan-caspase inhibitor (50 mM) at the time of transfection (c). Arrows in b and c show typical membrane blebs induced
by E4orf4 expression. Each panel shows a representative field within the population of transfected cells, selected to show typical effects
observed after we performed the same experiment at least four times. (B) 293T and H1299 cells were transfected with either FLAG–
GFP (left) or FLAG–E4orf4–GFP (right), and 16–20 h after transfection positive cells were examined by fluorescence confocal micros-
copy. Arrows show E4orf4–GFP-positive cells undergoing membrane blebbing. The pan-caspase inhibitor (50 mM) was added at the
time of transfection and did not affect E4orf4–GFP–induced membrane blebbing, whereas it strongly inhibited puromycin-induced cell
fragmentation in GFP-transfected cells treated with 10 mM puromycin for 16 h (bottom, compare puromycin/DMSO versus puromy-
cin/zVAD-fmk). (C) Fibronectin-induced spreading is inhibited in cells expressing E4orf4. 293T cells were transfected with either vec-
tor alone (a) or myc–E4orf4 (b). 20 h after transfection, cells were lifted up, resuspended in serum-free medium, transferred to fibronec-
tin-coated culture dishes, and allowed to spread for 60 min at 378C. Spreading of cells was observed by phase contrast, and panels show
the representative phenotypic effects observed. Percentages of spread cells were obtained by counting the cells presenting a flat mor-
phology with cellular extensions relative the total number of cells. At least 300 cells were counted for each condition and the data are
representative of three independent experiments (means 6 SE). Cell viability was assessed by Trypan blue exclusion on an aliquot of
cells taken up before plating on fibronectin (data not shown), and no significant effect on survival was measured at that time. (D) Fi-
bronectin adhesion is not inhibited by expression of E4orf4. 293T cells transfected with vector alone (EV) or myc–E4orf4 (E4orf4) were
processed as in C and after a 1-h incubation period at 378C cell adhesion to fibronectin was quantified as described in Materials and
Methods. Attached cells were fixed and stained, and absorbance was measured at 550 nm after extraction. The right side shows image of
a 96-well plate in which vector-only (EV) or E4orf4-transfected cells were allowed to attach, after extraction of the dye. Incubations
with integrin b1 blocking antibody before cell plating strongly inhibited cell adhesion showing specific attachment on fibronectin. Data
are the means 6 SE of two independent experiments performed in duplicate (graphical analysis).The Journal of Cell Biology, Volume 150, 2000 1042
importantly, up to 10% of the v-src expressed in the mem-
brane fraction (P2) was recovered in myc–E4orf4 immune
complexes (IPs), indicating that a subpopulation of E4orf4
present in cellular membranes was associated with v-src in
vivo (Fig. 2 B, left). Moreover, E4orf4–Src association also
was detected upon immunoprecipitation of endogenous
Src family kinases in 293T cells transfected with myc–
E4orf4 using a pan-src antibody (Fig. 2 C; SCRC2 IP). Par-
allel control experiments using unrelated rabbit serum did
not precipitate myc–E4orf4 protein in similar conditions
(Fig. 2 C, IgG IP). The association between E4orf4 and Src
family kinases was quite robust, since complexes were re-
covered under relatively stringent conditions (in modified
RIPA containing SDS). Coimmunoprecipitation of E4orf4
with endogenous Src family kinases was successfully per-
formed in CHO fibroblasts as well, indicating that E4orf4
association with Src kinases is not restricted to 293T cells
(data not shown).
E4orf4 and c-src Colocalize in Membrane Blebs and 
E4orf4 Association with the Cytoskeleton is Promoted 
by Overexpression of Activated Src Kinases
To study the physiological relevance of E4orf4 association
with Src family kinases, the subcellular distribution of the
two proteins was analyzed by immunofluorescence and
confocal microscopy. Cellular staining of endogenous Src
family kinases using rabbit SRC2 antibody was very faint
and close to background (Fig. 3 A, d and d9). Therefore,
c-src and activated c-src were overexpressed in either 293T
or H1299 cells to allow a better detection of its subcellular
localization. As previously reported (Reynolds et al., 1989;
Kaplan et al., 1994; Schaller et al., 1999), exogenous c-src
exhibited a diffuse staining pattern with prominent perinu-
clear and membrane staining in the two cell lines (Fig. 3 A,
b and b9). Immunostaining of NH2-terminal epitope-
tagged versions of E4orf4 (HA–orf4, myc–E4orf4; Fig. 3,
A and B), or non-tagged E4orf4 (Fig. 7), using anti-HA,
anti-myc, or purified rabbit anti-E4orf4 in either 293T or
H1299 cells gave similar staining patterns (Lavoie et al.,
1998). E4orf4 protein was diffusely distributed throughout
whole cells but in a majority of cells a stronger staining
was detected at the nuclear level (Fig. 3 A, c and c9), al-
though blebbing cells demonstrated a stronger cytoplas-
mic staining (see also Fig. 7 B). When E4orf4 and c-src
were coexpressed, the cytoplasmic staining of E4orf4 ap-
peared more intense (Fig. 3 A, e and e9,). More interest-
ingly, E4orf4 and c-src were colocalized in or surrounding
Figure 2. (A) E4orf4 associates with Src kinases in
vitro. Naive lysates of 293T cells were prepared as
described in Materials and Methods and incubated
with 4 mg of GST alone or with purified GST–E4orf4
bound to glutathione Sepharose. The beads were
washed and resuspended in SDS sample buffer and
the bound material was transferred onto nitrocellu-
lose after SDS-PAGE. Immunological detections
were performed using antibodies recognizing the
PP2A catalytic subunit (positive control), Src family
kinases, or NCK, and detection was performed by
chemiluminescence. For myc–E4orf4 binding to re-
combinant GST–c-src, the assay was performed as
described above, except that 293T lysates of cells
transfected with myc–E4orf4 were incubated with 4
mg of either GST or GST–c-src bound to glutathione
Sepharose. Total lysates (TL) represent 5% of the
input lysates. (B) Coimmunoprecipitation of v-src
with myc–E4orf4 in fractions of cellular membranes.
Transfections of v-src with EV, or v-src together
with myc–E4orf4 (E4orf4) were performed in 293T
cells. 24 h after transfection, cells were homogenized
and fractionated as described in Materials and Meth-
ods. Immunoprecipitations of myc–E4orf4 were per-
formed in each cellular fraction using anti–c-myc
antibody. The E4orf4 IPs were analyzed by SDS-
PAGE followed by electrotransfer onto nitrocellu-
lose, and immunological detections were performed
using Ab-1 anti-src antibody, and anti–c-myc anti-
body. Immunoblots of total lysates (TL) show the
levels of v-src expression and represent 5% of the in-
put lysates. (C) Coimmunoprecipitation of myc–
E4orf4 with endogenous Src family kinases. Myc–E4orf4 was transfected in 293T cells, and 24 h after transfection cells were processed for
fractionation as in B. Immunoprecipitations of endogenous Src family kinases were performed in P1 and P2 fractions using a pan-src an-
tibody (SRC2) which was replaced by unrelated rabbit serum in parallel experiments (IgG). The immune complexes were analyzed by
Western blot analysis after SDS-PAGE and electrotransfer onto nitrocellulose. Anti–c-myc antibody revealed the presence of the myc–
E4orf4 in Src family kinase IPs of the P2 fractions, whereas myc–E4orf4 was barely detected in IPs obtained using the unrelated rabbit
serum. Immunoblots of total lysates (TL) show the levels of endogenous Src family kinases and transfected myc–E4orf4 and represent
2% of the input lysates.Lavoie et al. Dysregulation of Src Family Kinases by Ad E4orf4 1043
Figure 3. (A) Immunolocalization of c-src and E4orf4. 293T cells
were transfected with c-src alone (a and b), HA–E4orf4 alone (c
and d), c-src together with HA-orf4 (e and f), or activated c-src
(Y527F) together with HA-orf4 (g and h) . Similar transfections
were performed in H1299 cells except that a myc–E4orf4 con-
struct was used (a9–h9). Double immunostaining using anti-SRC2
and anti-HA (a–h), or anti-SRC2 and anti-myc (a9–h9) was per-
formed 24 h after transfection as described in Materials and
Methods and specimens were analyzed by fluorescence confocal
microscopy. Typical staining of exogenous c-src in 293T (b, d, f,
and h) and H1299 cells (b9, d9, f9, and h9) are shown and E4orf4
staining in the same cells is presented in panels a, c, e, and g and
a9, c9, e9, and g9. Arrows show c-src and E4orf4 colocalization in
or surrounding membrane blebs. (B) Src kinase activity can mod-
ulate E4orf4 subcellular distribution. 293T cells were transfected with myc–E4orf4 alone, or together with c-src, kinase-dead c-src
(K295M), activated c-src (Y527F), or v-src. Cell extractions were performed in 0.5% Triton buffer and total proteins from equal por-
tions of the soluble (S) and insoluble (I) fractions were run on SDS-PAGE. The proportion of E4orf4, Src, and ERK in each fraction
was evaluated on immunoblots using anti–c-myc, Ab-1 anti-src, and rabbit anti-ERK, respectively, and E4orf4 distributions were quan-
titated from scanned enhanced chemiluminescence-derived images by densitometric analyses with the software program NIH Image.
membrane blebs. E4orf4 and c-src colocalization in mem-
brane area was even more striking in cells expressing an
activated c-src (Fig. 3 A, g, h, g9 and h9). This suggests that
subpopulations of E4orf4 and c-src proteins are localized
in close proximity within membrane regions that are in-
volved in bleb formation.
Previous studies have shown that activated c-src parti-
tions to Triton-insoluble cytoskeletal complexes (Clark
and Brugge, 1993; Kaplan et al., 1995; Schlaepfer et al.,
1998). To look biochemically at the effect of Src kinases on
the subcellular distribution of E4orf4, 293T cells were
transfected with myc–E4orf4 alone, or with myc–E4orf4
together with c-src, kinase-dead c-src (c-srcK295M), acti-
vated c-src (c-src Y527F), or v-src. Cell lysis was per-
formed in 0.5% Triton buffer to analyze E4orf4 distribu-
tion in the soluble (S) and insoluble (I) fractions. 24 h afterThe Journal of Cell Biology, Volume 150, 2000 1044
transfection, z30% of E4orf4 protein was recovered in
the insoluble fraction, indicating that a subpopulation of
E4orf4 is associated with cytoskeletal components (Fig. 3
B). In cells cotransfected with wild-type c-src or kinase-
deficient c-src, no major change in the distribution of
E4orf4 was observed, although a modest increase in the
amount of insoluble E4orf4 could be detected when wild-
type c-src was overexpressed. In contrast, when activated
c-src or v-src was coexpressed together with E4orf4, .60–
90% of E4orf4 protein was associated with the cytoskele-
tal fraction, together with increased levels of src species.
However, the cellular distribution of endogenous MAP ki-
nase ERK in the same lysates remained unaffected (Fig. 3
B, bottom). Interestingly enough, we observed an increase
in E4orf4 distribution to cytoskeletal fractions in absence
of activated Src 48 h after transfection (.55%; data not
shown). This suggests that translocation of E4orf4 to a cy-
toskeletal compartment may be associated with cell pro-
gression through the death pathway. Taken together, the
results indicate that a subpopulation of E4orf4 is associ-
ated with the cytoskeleton and that overexpression of acti-
vated Src kinases leads to increased levels of E4orf4 in cy-
toskeletal complexes.
Expression of E4orf4 Leads to a Specific Modulation of 
Src-mediated Tyrosine Phosphorylation of Cellular 
Substrates and Dysregulates Src-dependent Signaling at 
Focal Adhesion
To determine if E4orf4–Src association could have some
functional relevance, we looked at the tyrosine phosphory-
lation of cellular proteins induced by overexpression of
Src kinases, in the presence or absence of E4orf4 expres-
sion. Expression of E4orf4 did not induce a general up- or
downregulation of v-src, c-src, or activated c-src–depen-
dent tyrosine phosphorylation of cellular proteins (Fig.
4, A and B). Rather, there was a decrease in the tyro-
sine phosphorylation of specific proteins (200-, 125-kD
ranges), whereas some other proteins presented higher
levels of tyrosine phosphorylation (80–85-, 62-, 45–48-kD
ranges) in E4orf4/Src–expressing cells, as compared with
cells expressing comparable amounts of Src proteins alone
(Fig. 4 A, arrows). Furthermore, in vitro–labeled IPs of
endogenous Src isolated from E4orf4-only expressing cells
presented differences in the intensity of Src-associated
proteins as compared with control cells (EV). This indi-
cates that E4orf4 expression caused a modulation of en-
dogenous Src association with and phosphorylation of cel-
lular proteins (Fig. 4 B). However, no major difference
was observed between the in vitro kinase activity of c-src
isolated from E4orf4-expressing cells and from that of
cells expressing c-src alone, as measured on an exogenous
peptide substrate (data not shown). This suggests that
E4orf4 does not act primarily on Src intrinsic tyrosine ki-
nase activity but may rather lead to a modulation of Src-
dependent tyrosine phosphorylation of specific substrates.
Strong biochemical and genetic evidence has implicated
Src family kinases in integrin-mediated signaling at focal
adhesions and this event is concomitant with rapid ty-
rosine phosphorylation of focal adhesion proteins (Par-
sons, 1996; Burridge and Chrzanowska-Wodnicka, 1996;
Hanks and Polte, 1997; Klinghoffer et al., 1999). Recruit-
ment of Src family kinases to integrin-based signaling
complexes is thought to occur primarily via interaction
with another tyrosine kinase, FAK (Schlaepfer and Hun-
ter, 1996; Cobb et al., 1994; Schlaepfer et al., 1994; Schaller
et al., 1999). The subsequent phosphorylation of FAK by
Src family kinase at multiple tyrosine residues is believed
to increase its catalytic activity and allow further inter-
actions with other signaling proteins such as GRB2
Figure 4. Effect of E4orf4 expression on Src kinase-induced ty-
rosine phosphorylation of cellular proteins. (A) 293T cells were
transfected with v-src alone (EV/v-src) or together with E4orf4
(E4orf4/v-src); with c-src alone (c-src/EV) or together with
E4orf4 (c-src/E4orf4); or with activated c-src alone (c-srcY527F/
EV) or together with E4orf4 (c-srcY527F/E4orf4). 24 h after
transfection, cells were lysed either in hypotonic buffer and frac-
tionated in nuclear-enriched (P1) and membrane-enriched (P2)
fractions, or in SDS sample buffer. Equal amounts of total pro-
teins were run on SDS-PAGE and tyrosine phosphorylation of
cellular proteins was analyzed by immunoblotting using RC20-
HRPO antiphosphotyrosine. Immunoblots with Ab-1 anti-src
show the level of transfected v-src, and c-src species were de-
tected using SRC2 anti-src. Arrows indicate proteins presenting a
decreased or increased level of tyrosine phosphorylation in cells
expressing E4orf4. (B) 293T cells were transfected with EV or
with myc–E4orf4 (E4orf4). 24 h after transfection, cells were lysed
in modified RIPA, endogenous c-src was immunoprecipitated
from an equal amount of total proteins (800 mg), and Src IPs
were labeled by the addition of g-[32P]ATP. Labeled Src IPs were
resolved by SDS-PAGE and visualized by autoradiography
(short and long exposures are shown). Arrows indicate Src-asso-
ciated proteins differentially labeled in the IPs isolated from
E4orf4-expressing cells.Lavoie et al. Dysregulation of Src Family Kinases by Ad E4orf4 1045
(Schlaepfer and Hunter, 1996; Calalb et al., 1995; Schlaep-
fer et al., 1998). To characterize the effect of E4orf4 on
Src-dependent signaling and to gain insight into the molec-
ular mechanisms involved in E4orf4-dependent inhibition
of fibronectin-induced cell spreading, we studied whether
early expression of E4orf4 could affect the ability of Src to
send downstream signals to focal adhesion proteins. Over-
expression of v-src in H1299 or 293T cells led to an in-
crease in the tyrosine phosphorylation level of endoge-
nous FAK, which was associated with a dramatic increase
in its autophosphorylation (Fig. 5 A). This was consistent
with a previous report showing that Src-dependent phos-
phorylation of FAK in the kinase domain at Tyr-576–Tyr-
577 enhances FAK catalytic activity (Calalb et al., 1995).
In marked contrast, the tyrosine phosphorylation level of
endogenous FAK was not increased by v-src when E4orf4
was coexpressed, nor was the autophosphorylation stimu-
lated in these cells, indicating that E4orf4 expression led to
a strong inhibition of v-src–induced FAK phosphorylation
and activation. This was not due to inhibition of v-src ex-
pression by E4orf4, as equivalent expression levels were
detected in E4orf4-expressing cells (Fig. 5 A, TL). Fur-
thermore, a 50% decrease in the basal level of FAK phos-
phorylation was observed in cells expressing E4orf4 only,
suggesting that E4orf4 interfered with FAK phosphoryla-
tion by endogenous Src as well.
We next examined the v-src phosphorylation of two
other proteins: paxillin, a cytoskeletal protein that is ty-
rosine phosphorylated in response to cell adhesion and is a
likely substrate for FAK (Schaller and Parsons, 1995;
Burridge et al., 1992), and cortactin, an F-actin binding
protein that is a major substrate for Src family kinases
(Nada et al., 1994). As a consequence of E4orf4 expres-
sion, the basal level of paxillin tyrosine phosphorylation
was severely decreased (by 60–70%) and in E4orf4/v-src–
expressing cells, paxillin phosphorylation was also strongly
inhibited as compared with cells expressing v-src only (Fig.
5 B). This was consistent with inhibition of v-src–depen-
Figure 5. Expression of E4orf4 inhibits tyrosine phosphorylation of FAK and paxillin, whereas it increases tyrosine phosphorylation of
cortactin. (A) H1299 cells were transfected with EV (EV2), Flag–E4orf4 alone (E4orf42), or v-src alone (EV1) or together with Flag–
E4orf4 (E4orf41). 20 h after transfection, cells were lysed as described in Materials and Methods and endogenous FAK was immuno-
precipitated. Tyrosine phosphorylation was analyzed by immunoblotting of equal amounts of FAK IPs using RC20-HRPO antiphos-
photyrosine antibody (P-Tyr), after SDS-PAGE and electrotransfer onto nitrocellulose. Western blot analysis of the IPs with anti-FAK
is also shown, and the levels of E4orf4 and v-src in total lysates (TL) were analyzed by blotting with anti-Flag and Ab-1 anti-src, respec-
tively. Autophosphorylation of endogenous FAK was also analyzed in H1299 and 293T cells transfected as above, by incubating the FAK
immune complexes with g-[32P]ATP. Labeled FAK IPs were resolved by SDS-PAGE and visualized by autoradiography. (B) 293T cells
were transfected as in A and cells were lysed as described in Materials and Methods 24 h after transfection. Half of the lysates were im-
munoprecipitated with antipaxillin antibody, and the other half with anticortactin. Paxillin, cortactin, and tyrosine phosphorylation lev-
els of IPs were analyzed by Western blot using appropriate antibodies as indicated. The levels of expression in total lysates for trans-
fected E4orf4 and v-src, and for endogenous paxillin and cortactin are shown (TL). Note the decrease in v-src–induced tyrosine
phosphorylation of paxillin and the increased level of cortactin phosphorylation by v-src in lysate from E4orf4-expressing cells. (C)
293T cells were transfected with vector alone (2) or with myc–E4orf4 (1) and 24 h after transfection cells were lysed and equal
amounts of lysates (1.5 mg) were processed for immunoprecipitation using PY20 antiphosphotyrosine antibody. Equal amounts of IPs
were resolved by SDS-PAGE and analyzed by immunoblotting for FAK, paxillin, and cortactin using appropriate antibodies. The re-
sults show that in the same lysate isolated from E4orf4-expressing cells, there was less phosphorylated FAK and paxillin (74 and 50%
inhibition, respectively), whereas phosphorylated cortactin was more abondant (3.5-fold increase). The levels of FAK, paxillin, and
cortactin in IPs from control cells as compared with E4orf4-expressing cells were quantitated from scanned enhanced chemilumines-
cence–derived images by densitometric analyses with the software program NIH Image, and the results were corrected for transfection
efficiency (50% in 293T cells). Ponceau staining of total lysates and IgGs show equivalent amounts for the various analyses. Ponceau
staining of total proteins on SDS-PAGE is shown as loading control.The Journal of Cell Biology, Volume 150, 2000 1046
dent activation of FAK in E4orf4-expressing cells. In con-
trast, E4orf4 expression had no inhibitory effect on the
tyrosine phosphorylation of cortactin induced by v-src ex-
pression, but rather increased the phosphorylation of this
protein in the same lysates (Fig. 5 B). Interestingly, al-
though the p80/85 anticortactin antibody most frequently
recognized an 80-kD band on Western Blot analysis of
293T lysates (TL), it repeatedly immunoprecipitated dou-
blet bands (70–80-kD ranges) that could result from deg-
radation. However, the basal level of cortactin tyrosine
phosphorylation was barely detectable in 293T in these
conditions.
To study further the effect of E4orf4 on the tyrosine
phosphorylation of Src substrates in the absence of coex-
pressed activated Src, 293T cells were transfected with EV
or with E4orf4, and tyrosine phosphorylated proteins were
immunoprecipitated from equal amounts of denatured cell
lysates using antiphosphotyrosine antibody. The amounts
of endogenous FAK, paxillin and cortactin recovered in
IPs of tyrosine phosphorylated proteins were then deter-
mined by immunoblotting of equal amounts of IPs with
anti-FAK, antipaxillin, and anticortactin, respectively (Fig. 5
C). Once again, a strong decrease was observed in the
amount of FAK and paxillin proteins recovered in an-
tiphosphotyrosine IPs of E4orf4-expressing cells as com-
pared with control cells (74% and 50% inhibition, respec-
tively), further indicating that E4orf4 expression inhibited
the basal tyrosine phosphorylation of FAK and paxillin.
In contrast, there was a 3.5-fold increase in the amount
of cortactin recovered in antiphosphotyrosine IPs from
E4orf4-expressing cells as compared with control cells,
suggesting that tyrosine phosphorylation of cortactin was
increased in the same lysate of cells expressing E4orf4. Be-
cause we never succeeded in showing directly increased
cortactin phosphorylation in cortactin immunoprecipita-
tions (phosphotyrosine levels were undetectable in our
cell system), we can not completely rule out the possibility
that the increased recovery of cortactin in phosphoty-
rosine immunoprecipitations may result from E4orf4-
mediated changes in tyrosine phosphorylation of a cortac-
tin-associated protein. However, it is unlikely considering
that the lysates were denatured before immunoprecipita-
tion. At any rate, these observations strongly suggest that
expression of E4orf4 causes a specific inhibition of Src-
dependent tyrosine phosphorylation of focal adhesion
proteins, whereas it increases the tyrosine phosphorylation
of other Src substrates and, presumably, of cortactin.
A recent study reported that the simultaneous overex-
pression of FAK and c-src results in the enhancement of
the tyrosine phosphorylation of a limited number of cellu-
lar substrates, and that under these conditions paxillin phos-
phorylation is largely cell adhesion dependent (Schaller et al.,
1999). To further study the effect of E4orf4 expression on
Src-dependent signaling at focal adhesion, we examined
whether early expression of E4orf4 could affect the ty-
rosine phosphorylation of cellular proteins induced by
coexpression of FAK and c-src after transferring cells to fi-
bronectin-coated dishes in serum-free media for a 1-h pe-
riod. Overexpression of c-src alone induced an increase
mainly in the tyrosine phosphorylation of 60–62-kD pro-
teins in 293T cells (see Fig. 4 A for a higher exposure),
whereas overexpression of FAK alone resulted in little
change in the tyrosine phosphorylation pattern of cellular
proteins, except for the exogenous FAK itself that was
tyrosine phosphorylated (Fig. 6), as previously shown
(Schaller and Parsons, 1995; Schaller et al., 1999). How-
ever, when c-src and FAK were simultaneously expressed,
a dramatic increase in the tyrosine phosphorylation of cel-
lular proteins was detected (Fig. 6, c-src1FAK), indicating
that FAK and c-src cooperated to enhance the tyrosine
phosphorylation of cellular substrates. Coexpression of
E4orf4 together with FAK and c-src induced a strong inhi-
bition of the FAK/c-src–dependent stimulation of tyrosine
phosphorylation. This was not due to inhibition of FAK
and c-src expression by cotransfection of E4orf4, since
equivalent expression levels of the tyrosine kinases were
detected (compare myc-FAK, c-src, and myc–E4orf4 im-
munoblots in EV- versus E4orf4-transfected cells).
Figure 6. E4orf4 inhibits the tyrosine phosphorylation of cellular
substrates induced by coexpression of c-src and FAK. 293T cells
were transfected with c-src alone, myc-FAK alone, c-src together
with myc-FAK, or myc–E4orf4 alone, myc–E4orf4 and c-src,
myc–E4orf4 and myc-FAK, or a combination of the three plas-
mids. 24 h after transfection, cells were lifted, resuspended in se-
rum-free medium, transferred to fibronectin-coated dishes, and
incubated at 378C for a 1-h period before cell lysis in SDS sample
buffer. Equal amounts of total proteins were run on SDS-PAGE
followed by electrotransfer on nitrocellulose, and cell adhesion–
dependent tyrosine phosphorylation induced by coexpression of
c-src and FAK was evaluated in E4orf4-expressing cells (E4orf4),
as compared with control cells transfected with the correspond-
ing empty vector (EV). Immunoblotting was performed using
RC20-HRPO antiphosphotyrosine to visualize tyrosine phosphor-
ylation of cellular proteins, or with anti–c-myc and Ab-1 anti-src
to detect the expression levels of E4orf4 and FAK, or c-src, re-
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E4orf4 Expression Causes a Reorganization of Tyrosine 
Phosphorylated Proteins at Focal Adhesions, Actin 
Changes, and Relocation of Cortactin at the 
Cell Periphery
To correlate the early morphological changes observed in
E4orf4-expressing cells with E4orf4-induced dysregulation
of Src tyrosine phosphorylation, we examined the func-
tional consequences of E4orf4 expression on the localiza-
tion of tyrosine phosphorylated proteins at focal adhe-
sions. Proteins phosphorylated on tyrosine are normally
concentrated in focal adhesions, forming a typical pointed
pattern along the ventral face of spread cells (Fig. 7 A, a)
(Burridge et al., 1992). In E4orf4-expressing cells, the ty-
rosine phosphorylated proteins accumulated in patches,
forming bigger focal contacts clustered at the periphery of
cells adopting a rounder morphology (Fig. 7 A, c and e).
This phenotype was similar to that reported in FAK-defi-
cient cells (Ilic et al., 1995) and correlated with inhibition
of FAK phosphorylation in E4orf4-expressing cells. This
suggests that E4orf4 may trigger early changes in focal ad-
hesions resulting in a more static and round cell shape typ-
ical of the release phase of extranuclear apoptosis (Mills
et al., 1999). We then looked at the organization of actin fi-
bers that anchor at focal adhesions. Actin staining using
FITC-labeled phalloidin in 293T cells revealed a pattern of
very thin fibers spanning the ventral face of cells (Fig. 7 B,
a). Early expression of E4orf4 produced a dramatic rear-
rangement of actin into dense fibers that accumulated at
the periphery of the cells (Fig. 7 B, c–h), and later around
membrane blebs (Fig. 7 B, i and j). As actin is believed
to provide the force generation needed for membrane
blebbing (Mills et al., 1998), the redistribution of focal ad-
hesions that correlated with formation of a dense actin
network at the periphery of E4orf4-expressing cells may
underlie the accumulation of F-actin required for mem-
brane blebbing (Huot et al., 1998).
Cortactin is believed to be involved in the organization
and remodeling of the cortical actin skeleton (Vuori and
Ruoslahti, 1995; Patel et al., 1998). The protein has re-
cently been shown to translocate to the plasma membrane
after growth factor stimulation (Weed et al., 1998) and hy-
pertonicity-induced cell shrinkage (Kapus et al., 1999). Al-
though the role of its tyrosine phosphorylation has not
been clarified entirely, cytoskeletal changes have been as-
sociated with it (Wu et al., 1991; Nada et al., 1994; Huang
et al., 1997). Because E4orf4 expression appeared to in-
crease Src-mediated phosphorylation of cortactin, we ex-
amined the subcellular localization of cortactin in E4orf4-
expressing cells as compared with cells transfected with
EV. Control cells displayed cortactin staining within the
cytoplasm and perinuclear area as previously shown in
other cell types (Huang et al., 1998; Fig. 7 C, a). However,
in cells expressing E4orf4, the distribution of cortactin was
altered, being enriched at the cortical membrane in re-
gions where membrane protrusions started to form (Fig. 7
C, c and d). Interestingly, E4orf4 also localized to these
cortical regions, and in cells undergoing blebbing cortactin
and E4orf4 were enriched in membrane blebs (Fig. 7 C, e
and f). Thus the increased phosphorylation of cortactin
correlated with its redistribution to cortical structures in
E4orf4-expressing cells adopting a rounder morphology,
although it is not yet clear whether the tyrosine phosphor-
ylation of cortactin is required for its relocation to mem-
brane blebs.
E4orf4-induced Membrane Blebbing and Nuclear 
Condensation Is Regulated by Src Kinase Activity
To assess the role of Src family kinases in E4orf4-medi-
ated membrane blebbing and apoptosis, a cotransfection
assay was developed in 293T cells, using GFP as a reporter
to visualize the cellular morphology in live cells. Overex-
pression of activated mouse or chicken c-src alone did not
induce membrane blebbing, but when expressed together
with E4orf4, the number of GFP-positive blebbing cells
was increased by more than twofold as compared with
cells expressing E4orf4 alone (Fig. 8 A). Furthermore, the
extent of blebbing within individual cells was markedly
potentiated in terms of number and size of blebs per cell,
which showed a “popcorn-like” morphology (Fig. 8 A, ar-
rows). In contrast, coexpression of the kinase-deficient
mouse and more significantly of the kinase-dead chicken
c-src together with E4orf4 consistently inhibited the ap-
pearance of blebbing cells (50% inhibition with chicken
kinase-dead c-src/ccsrcK295R). More strikingly, positive
cells demonstrated a flat morphology and the size and
number of blebs within individual cells was strongly de-
creased. In these conditions, the kinase-deficient chicken
c-src construct was better expressed in 293T cells than was
the mouse c-src, which may explain the stronger inhibition
of E4orf4-induced membrane blebbing; when higher levels
of expression were achieved with mouse c-srcK295M,
E4orf4 expression was strongly increased and no clear in-
terpretations could be made. A strong correlation was es-
tablished between the extent of membrane blebbing ob-
served 24 h after transfection and E4orf4-dependent DNA
condensation 48 h after transfection. Again, coexpression
of activated c-src constructs and E4orf4 produced more
than twofold increase in the number of GFP-positive cells
presenting an apoptotic nuclear morphology, and the ex-
tent of nuclear shrinkage and condensation was also
higher. On the other hand, expression of kinase-deficient
c-src constructs to a similar level inhibited the appearance
of apoptotic nuclei by 30–50% as compared with cells ex-
pressing E4orf4 only (Fig. 8 B). Additionally, the extent of
E4orf4-dependent DNA condensation was markedly de-
creased as revealed by a smaller degree of nuclear shrink-
age and lower intensity in DAPI staining (Fig. 8 B, ar-
rows). As the level of E4orf4 expression was similar in
cells expressing the activated c-src and the kinase-deficient
c-src, the difference measured in E4orf4-mediated mem-
brane blebbing and apoptosis probably resulted from dif-
ferences in Src kinase activity (Fig. 8 C).
As another approach, we used chemical inhibitors in at-
tempts to reverse the blebbing phenotype in 293T cells ex-
pressing high levels of E4orf4. 24 h after E4orf4/GFP
transfection, cells were incubated for 1 h in the presence of
either a selective inhibitor of Src family kinase activity,
PP2 (Hanke et al., 1996), or genistein, a general tyrosine
kinase inhibitor. Additionally, PP3, which has no inhibi-
tory effect on Src family kinase activity but inhibits the ac-
tivity of EGFR kinase (Traxler et al., 1997), was used as a
negative control, and the actin polymerization inhibitorThe Journal of Cell Biology, Volume 150, 2000 1048
Figure 7. E4orf4-induced focal adhesion misassembly, actin changes, and translocation of cortactin to the cell periphery. (A) Redistri-
bution of tyrosine phosphorylated proteins at the cell periphery, and increased size of focal contacts in E4orf4-expressing cells. H1299
were plated on fibronectin-coated culture slides and transfected with vector alone (a and b) or E4orf4 (c–f). 16 h after transfection, cells
were fixed and double stained for antiphosphotyrosine (a, c, and e) and E4orf4 (b, d, and f), using PY20 antiphosphotyrosine and rabbitLavoie et al. Dysregulation of Src Family Kinases by Ad E4orf4 1049
cytochalasin D was used as a positive control to inhibit
membrane blebbing, as previously reported (Huot et al.,
1998; Mills et al., 1998). After a 1-h incubation period in
the presence of cytochalasin D, E4orf4-dependent mem-
brane blebbing was strongly inhibited as compared with
cells treated with vehicle only (Fig. 9, A and B). This was
consistent with the notion that the actin skeleton is re-
quired for membrane blebbing. More importantly, inhibi-
tion of membrane blebbing by cytochalasin D correlated
with a marked decrease in the number of E4orf4-express-
ing cells presenting apoptotic nuclear morphology 48 h af-
ter transfection (24 h after cytochalasin D addition). This
strongly suggests that the early morphological changes that
precede cell death are involved in signaling execution of
E4orf4-dependent death pathway. Significantly, E4orf4-
induced membrane blebbing was similarly inhibited after a
1 h-treatment in the presence of PP2 (Fig. 9, A and B),
when used at a concentration that inhibited the tyrosine
phosphorylation of cellular proteins induced by overex-
pression of activated c-src in parallel experiments (data
not shown). However, under the same experimental con-
ditions, PP3 did not interfere with E4orf4-induced mem-
brane blebbing but rather consistently produced a modest
increase, whereas genistein decreased E4orf4-dependent
blebbing less efficiently than PP2. Consistent with a func-
tional role for E4orf4-dependent modulation of Src activ-
ity, PP2 produced a twofold decrease in the number of ap-
optotic E4orf4-expressing cells 48 h after transfection (Fig.
9 B). Taken together, the results strongly suggest that
modulation of Src kinase activity by E4orf4 is involved in
triggering E4orf4-dependent membrane blebbing and ap-
optosis.
Discussion
We have shown previously that expression of Ad E4orf4 is
sufficient to trigger a p53-independent apoptosis pathway
that does not require activation of the zVAD-fmk–inhib-
itable caspases (Lavoie et al., 1998). Our present study
provides two original and important findings. First, the re-
sults strongly suggest that E4orf4 action as a death factor
may rely on its ability to associate with and dysregulate Src
family kinase signaling at focal adhesions. Second, evi-
dence is provided that E4orf4-induced early membrane
blebbing is modulated by Src family kinase activity and is
involved in triggering execution of the death pathway. Fi-
nally, the data obtained using E4orf4 as a model system
suggest that modulation of Src family kinases could play a
role in the cytoplasmic execution of apoptotic pathways,
characterized by caspase-independent changes in cellular
morphology and membrane blebbing.
Src Family Kinases and Downstream Signaling 
Pathways As Direct Targets of the Ad E4orf4
Death Factor
When looking at the early steps of E4orf4-induced cell
death, we found that cells undergo a rapid change in mor-
phology associated with cell rounding, membrane blebbing,
and inhibition of fibronectin-induced cell spreading. This
phenotype appeared as early as 10 to 16 h after transfec-
tion and before the onset of DNA condensation in 293T
cells, indicating that the changes in cellular morphology
probably preceded the ensuing death of the cells. We
found that E4orf4 can associate with Src family kinases
both in vitro and in vivo, and that expression of E4orf4
leads to a rapid and specific modulation of Src-dependent
tyrosine phosphorylation of cellular proteins, rather than
causing a general up- or downregulation of kinase activity.
More specifically, early expression of E4orf4 inhibited Src-
dependent tyrosine phosphorylation of focal adhesion–
associated proteins such as FAK and paxillin, whereas
other Src substrates, such as cortactin, presented higher
levels of tyrosine phosphorylation. This was correlated
with a redistribution of tyrosine phosphorylated proteins
at the periphery of the cells, leading to a misassembly of
focal adhesions that was accompanied by a dramatic reor-
ganization of the actin skeleton. FAK is believed to play a
major role in the dynamic turnover of focal adhesions es-
sential for cell spreading and migration (Ilic et al., 1995).
As Src family kinases are important regulators of tyrosine
phosphorylation at focal adhesions (Klinghoffer et al.,
1999), E4orf4 inhibition of Src/FAK-dependent signaling
may be required to trigger the initial phase leading to
E4orf4-dependent changes in cell shape allowing mem-
brane blebbing.
E4orf4 effect on Src-dependent tyrosine phosphoryla-
tion was similar to that reported by inhibiting Src recruit-
2418 anti-E4orf4, respectively. Specimens were analyzed by fluorescence confocal microscopy. Panel a shows the ventral face of repre-
sentative control cells to visualize the organization of tyrosine phosphorylated proteins at focal contacts. Arrows in b and e show increased
focal contacts formed by tyrosine phosphorylated proteins that relocated at the cell periphery and are more apical in E4orf4-expressing
cells, as they started to adopt a rounder morphology before the onset of membrane blebbing. (B) E4orf4-induced reorganization of the
actin cytoskeleton. 293T cells were transfected with vector only (a and b) or with HA–E4orf4 (c–j), and 24 h after transfection cells were
fixed and double stained for actin filaments and E4orf4 using FITC-labeled phalloidin and anti-HA followed by Texas Red–labeled
anti–mouse, respectively. Specimens were analyzed by fluorescence confocal microscopy and representative control cells (a and b) or
E4orf4-expressing cells in various stages of blebbing (c–j) are shown. Panels c–h show examples of E4orf4-expressing cells in the early
stages of membrane blebbing when actin reorganized into very dense fibers at the cell periphery (arrows), whereas i and j show a typical
E4orf4-expressing cell in the active-late stage of membrane blebbing, when actin accumulated around membrane blebs that contain
high amounts of E4orf4 protein. (C) Expression of E4orf4 induces early redistribution of cortactin at the cell periphery and in mem-
brane blebs. H1299 seeded in fibronectin-coated culture slides were transfected with vector only (a and b) or with E4orf4 (c–f). 24 h af-
ter transfection, cells were fixed and double stained for endogenous cortactin (a, c, and e) and transfected E4orf4 (b, d, and f) using mouse
anticortactin (Transduction Laboratories) and rabbit 2418 anti-E4orf4, respectively. Specimens were analyzed by fluorescence confocal
microscopy and representative cells are shown. In typical control cells (EV), cortactin was present diffusely in cytoplasmic and perinu-
clear regions (a and b). In E4orf4-expressing cells that started to round up, cortactin was enriched at the cortical membrane, and colo-
calized with E4orf4 in membrane protrusions (arrows in c and d). Panels e and f show E4orf4-positive cells undergoing active blebbing,
in which cortactin and E4orf4 staining were enriched in membrane blebs.The Journal of Cell Biology, Volume 150, 2000 1050
Figure 8. E4orf4-induced membrane blebbing and apoptosis is modulated by Src kinase activity. (A) 293T cells were transfected with
0.25  mg of Flag-GFP and 3 mg of empty vector (GFP1EV) alone, or together with 1 mg of activated mouse or chicken c-src
(mcsrcY527F/ccsrcY527F) or 1 mg of mouse or chicken kinase-deficient c-src (mcsrcK295M/ccsrcK295R). In parallel experiments, simi-Lavoie et al. Dysregulation of Src Family Kinases by Ad E4orf4 1051
ment to integrins upon depletion of caveolin by antisense
methodology in kidney 293 cells (Wei et al., 1999). Indeed,
the possibility that E4orf4 association with Src kinases
could regulate Src interactions with specific cellular pro-
teins is supported by experiments showing that E4orf4 can
interfere with the ability of FAK and c-src to cooperate in
induction of tyrosine phosphorylation of cellular sub-
strates. A recent study has provided evidence that FAK
may function to direct phosphorylation of cellular sub-
strates by recruitment of Src kinases (Schaller et al., 1999).
FAK can associate with Src kinases via an SH2-dependent
interaction involving the major site of FAK autophos-
phorylation, tyrosine 397 (Cobb et al., 1994; Schaller et al.,
1994; Xing et al., 1994; Eide et al., 1995), and additionally,
FAK contains a binding site for the SH3 domain of Src
that may contribute to stabilization of the FAK–Src com-
plex (Thomas et al., 1998). Although the molecular deter-
minants of E4orf4/Src association has not been deter-
mined yet, preliminary results indicated that a highly
conserved NH2-terminal, proline-rich motif, which con-
tains a consensus sequence for Src family kinase SH3 bind-
ing (LPxLPxPP), can mediate E4orf4 binding to v-src SH3
domain in vitro (our unpublished data), raising the possi-
bility that E4orf4 could change substrate binding via the
SH3 domain. We have also observed that E4orf4 itself is
tyrosine phosphorylated in cells coexpressing activated
c-src or v-src, and that E4orf4 contains two potential con-
sensus sequences for Src kinase SH2-binding (our unpub-
lished data). However, it is not clear yet whether E4orf4
directly binds physically to Src family kinases in vivo, if
E4orf4 association with Src kinases is facilitated by bind-
ing to another protein like PP2A as is the case for poly-
omavirus middle T antigen (Markland and Smith, 1987;
Glenn and Eckhart, 1993; Glenn and Eckhart, 1995;
Campbell et al., 1995), or, alternatively, if E4orf4/Src asso-
ciation is indirect and mediated by adaptor molecules.
Whatever the case, the results clearly show that E4orf4 ex-
pression interferes with Src signaling to focal adhesion and
future work will help clarify the molecular mechanisms
that are involved in E4orf4 modulation of Src kinase activity.
A Positive Role for Src Kinase Activity in E4orf4 
Signaling of Caspase-independent Apoptosis
Functional analysis in cells coexpressing either activated
c-src or kinase-deficient c-src together with E4orf4 re-
vealed a close correlation between Src kinase activity,
E4orf4-dependent membrane blebbing, and E4orf4-medi-
ated DNA condensation. Furthermore, inhibition of Src
family kinase activity using the selective inhibitor PP2
strongly inhibited membrane blebbing in E4orf4-express-
ing cells and as a consequence, E4orf4-mediated DNA
condensation was markedly decreased. Although PP2 was
shown recently to inhibit PDGFR and Abl tyrosine ki-
nases, as well as some serine kinases (Liu et al., 1999), in-
hibition of E4orf4-induced apoptosis by this more selec-
tive inhibitor was consistent with a similar inhibition
observed using Src interfering constructs (see level of inhi-
bition Fig. 8, A and B). The milder inhibition observed
in the presence of genistein may be explained by the
broader inhibitory action of this tyrosine kinase inhibitor,
that may impact on signaling pathways important for sur-
vival, thus introducing unspecific toxic effects in these as-
says. Additionally, genistein was found to be less potent
than PP2 in inhibiting the increased tyrosine phosphoryla-
tion induced by activated Src in our cell system (data not
shown), although the reason for this is not clear. However,
pharmacological analysis coupled with coexpression ex-
periments strongly suggests that E4orf4 association with
and modulation of Src kinase activity is likely to play an
active role in mediating the early changes in cell shape,
which may require the regulation of other signaling mole-
cules by positive phosphorylation in addition to downreg-
ulation of FAK signaling at focal adhesions. It also implies
that early membrane blebbing can be required as part of a
discrete apoptotic program leading to caspase-indepen-
dent nuclear condensation and cell death, supporting pre-
vious observations made in other apoptotic systems when
caspase activity was inhibited (McCarthy et al., 1997). The
observation that treatment with the actin polymerization
inhibitor cytochalasin D resulted in a similar reversion of
E4orf4-dependent membrane blebbing and later to inhibi-
tion of nuclear condensation further indicates that mem-
brane blebbing is involved in signaling E4orf4 death path-
way and stresses that the morphological changes occur
before execution of the death pathway. These data also
emphasize the importance of actin polymerization and re-
modeling in the release and blebbing phase of extranu-
clear apoptotic mechanisms.
The change in morphology associated with the release
lar transfections were performed except that the empty vector was replaced by myc–E4orf4 (2mg; GFP1E4orf4). 24 h after transfection,
the cellular morphology of transfected cells was examined in live cells and typical blebbing phenotypes of E4orf4-expressing cells are
presented on the right. Arrows show the “popcorn-like” morphology of GFP-positive cells cotransfected with E4orf4 and activated c-src
plasmids that presented a higher number and size of blebs in individual cells, as compared with GFP-positive cells transfected with
E4orf41GFP only. At least 300 GFP-positive cells were counted for each transfection and the percentage of blebbing cells was deter-
mined from the number of GFP-positive cells that arbored more than one bleb per cell relative to the total number of GFP-positive cells
(graphical representation on the right). The data are the means 6 SE of at least three independent experiments. (B) The same cells
were kept at 378C for an additional 24 h (48 h after transfection), following witch non-adherent and adherent cells were washed in PBS
and the nuclear morphology was analyzed by DAPI staining after cell fixation. Specimens were analyzed by fluorescence microscopy
and representative GFP-positive cells (GFP staining) with the corresponding nuclear staining (DAPI) are presented for each transfec-
tion. Arrows show GFP-positive cells that presented typical E4orf4-dependent apoptotic nuclear morphology. Percentages of apoptotic
nuclei were obtained by counting at least 300 GFP-positive cells for each condition and are expressed as the number of cells presenting
nuclear condensation relative to the total number of GFP-positive cells. The data are representative of at least three independent exper-
iments (means 6 SE). (C) Before cell fixation, aliquots of each cell population were kept and lysed in SDS sample buffer. Expression lev-
els of exogenous proteins were analyzed by immunoblotting with the corresponding antibodies as indicated and tyrosine phosphoryla-
tion of cellular proteins was visualized using RC20-HRPO antiphosphotyrosine for immunoblot analysis of equal amounts of total
proteins run on SDS-PAGE followed by electrotransfer onto nitrocellulose (Ponceau staining of gels are shown as loading controls).The Journal of Cell Biology, Volume 150, 2000 1052
phase of extranuclear apoptosis was shown to correlate with
a reorganization of actin into a peripheral cortical ring
(Bannerman et al., 1998; Huot et al., 1998; Levkau et al.,
1998). Soon after E4orf4 expression, we observed high
amounts of polymerized actin forming dense fibers that
accumulated at the cell periphery, indicating that E4orf4
may directly signal actin changes required for a rounder
cell shape and force generation for membrane blebbing.
Actin polymerization (Huot et al., 1998), actin-membrane
linking proteins (Martin et al., 1995; Cryns et al., 1996;
Nath et al., 1996; Wang et al., 1998), and small GTPases
(Rudel and Bokoch, 1997; Lee et al., 1997; Mills et al.,
1998) have been implicated in apoptosis-related morpho-
logical changes and membrane blebbing. Immunolocaliza-
tion of E4orf4 revealed that a subpopulation of the protein
is localized in membrane blebs, together with exogenously
expressed c-src. Furthermore, biochemical evidence was
obtained that E4orf4 can associate with cytoskeletal com-
Figure 9. Src family kinase activity is required for maximal E4orf4-induced membrane blebbing and apoptosis. (A) 293T cells were trans-
fected with 3 mg of myc–E4orf4 together with 0.25 mg of Flag–E4orf4. 24 h after transfection, various drugs were added in individual cul-
tures of E4orf4-expressing cells as follows: 0.2% DMSO (vehicle only), 1 mM cytochalasin D, 50 mM PP2, 100 mM genistein, or 50 mM
PP3. 1 h after addition of the drugs, the cellular morphology of GFP-positive cells was examined. Arrows show cells undergoing E4orf4-
dependent membrane blebbing, which was strongly inhibited in cell populations treated with cytochalasin D or with the Src family ki-
nase inhibitor PP2. (B) Quantification of the effects of chemical drugs on E4orf4-dependent membrane blebbing and on E4orf4-depen-
dent apoptosis 24 h after addition of the drugs (48 h after E4orf4 transfection). 1 h after addition of the drugs, at least 300 GFP-positive
cells were counted for each treatment (described in A) and the percentage of blebbing cells was determined from the number of GFP-
positive cells arboring more than one bleb per cell relative to the total number of GFP-positive cells. The data are representative of at
least three independent experiments. Cells were then kept for an additional 24 h at 378C, following which non-adherent and adherent
cells were washed in PBS and the nuclear morphology was analyzed by DAPI staining after cell fixation. Specimens were analyzed as
described in Fig. 8 B, and the percentages of apoptotic nuclei were obtained by counting at least 300 GFP-positive cells for each condi-
tion and are expressed relative to the number of cells presenting nuclear condensation relative to the total number of GFP-positive
cells. The data are representative of at least three independent experiments. (C) Before cell fixation, aliquots of each cell population
were kept and lysed in SDS sample buffer. Expression levels of exogenous Flag–GFP and myc–E4orf4 were analyzed by immunoblotting
with anti-Flag and anti–c-myc antibodies, respectively, and show equivalent amounts of E4orf4 for each condition.Lavoie et al. Dysregulation of Src Family Kinases by Ad E4orf4 1053
ponents and, interestingly enough, higher amounts of
E4orf4 were found associated with the cytoskeleton when
activated Src were expressed. Although it is not clear yet
if E4orf4 distribution to cytoskeletal fractions required
E4orf4/Src association and/or modulation by endogenous
Src kinases, the data clearly indicate that an increase in Src
kinase activity can modulate E4orf4 distribution to the cy-
toskeleton, where E4orf4 could signal actin remodeling. In
cells expressing E4orf4, cortactin together with E4orf4 re-
localized in cortical membrane regions and later in mem-
brane blebs. Moreover in v-src–expressing cells, cortactin
phosphorylation was increased in the presence of E4orf4
and the results obtained upon phosphotyrosine immuno-
precipitations from cells expressing E4orf4 only are also
consistent with increased tyrosine phosphorylation of cort-
actin. In principle, the increased tyrosine phosphorylation
of cortactin induced by E4orf4 expression, along with its
redistribution to the cortical membrane, could play an ac-
tive role in reorganizing the actin cytoskeleton during the
release stage and/or the blebbing phase. In vitro phosphor-
ylation of cortactin by Src was shown to downregulate its
actin cross-linking activity (Huang et al., 1997), and hyper-
tonicity-induced cell shrinkage was associated with phos-
phorylation of cortactin by the Src family kinase member
fyn, suggesting a role in shrinkage-related reorganization
of cytoskeleton (Kapus et al., 1999). However, still it is not
clear whether phosphorylation of cortactin is required for
actin remodeling and E4orf4 might provide a molecular
tool to understand the regulation of cortactin function and
its potential role in membrane blebbing. Nevertheless, al-
though a clear modulation of cortactin localization by
E4orf4 was observed, more direct evidence that E4orf4 can
modulate cortactin phosphorylation by endogenous ki-
nases in other transformed cell lines will be needed. The
dramatic reorganization of the actin skeleton observed in
E4orf4-expressing cells also raises the possibility that
E4orf4 may modulate the activity of the major regulators
of actin dynamic, the small Rho GTPases. This GTP-bind-
ing protein family for which the best characterized mem-
bers are Cdc42, Rac1, and RhoA, was shown to control
diverse biological processes such as cytoskeletal organiza-
tion, gene transcription, adhesion, and apoptosis (for re-
view see Aspenstrom, 1999). Indeed, all three major Rho
family members were recently involved in CTL- and Fas-
induced killing, presumably through their effect on the ac-
tin cytoskeleton (Subauste et al., 2000), illustrating the
complex multifunctional role of the Rho proteins in apop-
tosis induction. As Src family kinases are believed to mod-
ulate Rho activity through tyrosine phosphorylation of the
p190 RhoGAP protein (Chang et al., 1995; Roof et al.,
1998; Fincham et al., 1999), one possibility is that E4orf4
would cause actin changes via regulation of Rho function
through modulation of Src family kinases. In future stud-
ies, we hope to elucidate the molecular mechanisms in-
volved in E4orf4-dependent remodeling of the actin skele-
ton and thus to identify specific actin structures and
dynamics involved in apoptosis induction.
In light of the results presented in this paper, we pro-
pose that E4orf4 may trigger the direct entry of cells into
the release and blebbing phases of extranuclear apoptosis.
E4orf4 would cause a misassembly of focal adhesions
through inhibition of Src-dependent regulation of FAK
signaling, coupled with a reorganization of the actin cy-
toskeleton through modulation of actin regulators such as
cortactin. In a number of studies, integrin–FAK signaling
complexes have been implicated in the regulation of an-
chorage-dependent cell survival, and upregulation of FAK
signaling was shown to transform cells by providing sur-
vival signals allowing anchorage-independent growth (Frisch
et al., 1996; Hungerford et al., 1996). As Src transforma-
tion was reported to protect MDCK cells and HUVECs
from anoikis (Frisch and Francis, 1994; Re et al., 1994), Src
family kinase activation may mimic ECM survival signals
required by transformed cells (irrespective of cell type) to
survive in suspension. This suggests that malignant cells
must somehow upregulate signaling intermediates in this
adhesion pathway (like Src) in order to metastasize, and to
survive and grow in inappropriate environments. The ob-
servation that E4orf4 can target and dysregulate Src-depen-
dent signaling could provide part of an explanation for the
apparent E4orf4 selectivity towards transformed cells
(Shtrichman et al., 1999). Our data also support a model in
which oncogenes such as Src may cotransduce survival and
proapoptotic signals, and that the balance between those
in a given tissue would be a critical determinant in the ini-
tiation and maintenance of a tumor (Pelengaris et al.,
2000). Our work also provides the first evidence that adeno-
viruses express a protein capable of associating with and
altering the function of Src-related kinases, as is the case
for most DNA tumor viruses (Messerschmitt et al., 1997).
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